CN
Tel:+86-755-36307888
Fax:+86-755-36307273
Service Email:info@genomics.cn
Media contact:media@genomics.cn
Address:Building 11, Beishan Industrial Zone, Yantian District, Shenzhen(518083)

      

    News Center

News Center

Updates on BGI’s developments in research, education and industry.

首页 About News Center Social Responsibility Public Health 列表 2009 Preventative Oncology International (POI) Cooperates with BGI and Peking University Shenzhen Hospita...

Preventative Oncology International (POI) Cooperates with BGI and Peking University Shenzhen Hospital

Release date:2018/12/29 Views:

The US-based oncology research organization Preventative Oncology International (POI) forms collaboration with BGI and Peking University Shenzhen Hospital using MALDI-TOF HPV detection on BGI’s high-throughput PCR platform in the well-known Shenzhen Cervical Cancer Prevention Research Project II (SHENCCAST II) to study and compare large volumes of clinical samples taken by a doctor and samples conducted by the patients.

The results confirm that the MALDI-TOF self-conducted sample test results have the same effect on the sensitivity and specificity as the results of the HC-2 doctor's sample test, with no significant difference. This technology solves the conventional issues e.g. reliance on seeing a doctor for a cervical cancer screening, and low-throughput but high-detection-cost sampling and screening techniques. It makes it possible for the patients to take their own samples, and the test centers to larger volumes of samples using high-throughput technology at much lower costs.